Modeling GATA2 Associated MDS/AML Predisposition Syndrome Using Color-Barcoding and Mutagenesis in Zebrafish |
Dana-Farber Cancer Institute / Serine Avagyan, PhD |
Young Investigator Grants |
2018 |
Massachusetts |
Identification of Synthetically Immunogenic Compounds to Synergize with Immunotherapy in Neuroblastoma |
Children’s Hospital of Philadelphia / Adam Wolpaw, MD/PhD |
Young Investigator Grants |
2019 |
Pennsylvania |
A CRISPRi Genetic Screen in Ewing sarcoma Identifies a Novel Dependence on Homologous Recombination DNA Repair |
University of California San Francisco / Asmin Tulpule, MD/PhD |
Young Investigator Grants |
2016 |
California |
Identifying Disease Mechanisms and Therapeutic Opportunities in Pediatric Low-grade Gliomas Driven by MYB-QKI Fusions |
Dana-Farber Cancer Institute / Cecile Rouleau, PhD |
Young Investigator Grants |
2017 |
Massachusetts |
Targeting the Metabolic Drivers of Chemo Resistance in Acute Myeloid Leukemia |
Harvard University / Nick van Gastel, PhD |
Young Investigator Grants |
2018 |
Massachusetts |
Enhancing the therapeutic efficacy of chimeric antigen receptor T cells for acute myeloid leukemia |
Washington University / Miriam Kim, MD |
Young Investigator Grants |
2019 |
Missouri |
Modeling osteosarcoma to identify novel therapeutic targets.
|
Stanford University / Julien Sage |
Young Investigator Grants |
2006 |
California |
The Role of ARID1A in Neuroblastoma Pathogenesis |
Dana-Farber Cancer Institute / Hui Shi, PhD |
Young Investigator Grants |
2016 |
Massachusetts |
Role of N6-Methyladenosine (m6A) mRNA Modification Pathway in Neuroblastoma |
Boston Children’s Hospital / Shuibin Lin, PhD |
Young Investigator Grants |
2017 |
Massachusetts |
Identification of FDA approved drugs with anti-tumor activity in rhabdomyosarcoma.
|
Massachusetts General Hospital / David Langenau |
Young Investigator Grants |
2009 |
Massachusetts |